Back
PGIM Global High Yield Fund Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
41
GHY
PGIM Global High Yield Fund
Last Price:
$11.59
Seasonality Move:
-3.13%
Sell
27
NVO
Novo Nordisk A/S
Last Price:
$36.97
Seasonality Move:
12.55%
Sell
41
PGIM Global High Yield Fund (GHY)
is a Sell
Is PGIM Global High Yield Fund a Buy, Sell or Hold?
-
The current PGIM Global High Yield Fund [GHY] share price is $11.59. The Score for GHY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
GHY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $36.98. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GHY Stock Price Chart
What is PGIM Global High Yield Fund's stock price today?
-
The PGIM Global High Yield Fund share price today is $11.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GHY is experiencing slight buying pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $36.98Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GHY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.56 | Buy |
| Relative Strength Index (14 RSI): | 37.69 | Sell |
| Chaikin Money Flow: | 12745 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.54 - 12.3) | Sell |
| Bollinger Bands (100): | (12 - 12.78) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.87 | Sell |
| Relative Strength Index (14 RSI): | 39.83 | Sell |
| Chaikin Money Flow: | 14566902 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.41 - 38.59) | Sell |
| Bollinger Bands (100): | (39.84 - 55.48) | Sell |
GHY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.56 | Buy |
| 20-day SMA: | 11.77 | Sell |
| 50-day SMA: | 12.38 | Sell |
| 200-day SMA: | 12.73 | Sell |
| 8-day EMA: | 11.38 | Buy |
| 20-day EMA: | 9.28 | Buy |
| 50-day EMA: | 5.51 | Buy |
| 200-day EMA: | 1.73 | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.4 | Buy |
| 20-day SMA: | 37.4 | Sell |
| 50-day SMA: | 44.19 | Sell |
| 200-day SMA: | 53.09 | Sell |
| 8-day EMA: | 36.61 | Buy |
| 20-day EMA: | 37.8 | Sell |
| 50-day EMA: | 42.18 | Sell |
| 200-day EMA: | 54.43 | Sell |
PGIM Global High Yield Fund Earnings Growth & GHY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.05 per share.
PGIM Global High Yield Fund Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||